What's breaking now, across thousands of outlets.
The court was hearing Mhatre's challenge to stringent conditions imposed by the Bombay High Court while granting him relief in the Dombivli assault case.
We haven't written up this one. ETHealthworld has the full story — the link below goes straight to it.
In the wake of its high-profile setback in heart disease late last week, Novartis really needed a win. It didn’t get one. The Swiss pharma said Tuesday that in a late-stage ...
KUALA LUMPUR, Sept 8 — When Puan Suzana was diagnosed with breast cancer, she expected chemotherapy to be the toug...
An HFA report estimates that 8,79 million South Africans earn above the tax threshold but remain outside medical schemes, as contributions rise faster than many household incomes.
The decision to move ahead with new products in the absence of FDA authorization could spur other big manufacturers to do the same, one tobacco-nicotine expert said.
When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for quick access have been stymied.
